View ValuationNova Wellness Group Berhad 향후 성장Future 기준 점검 2/6Nova Wellness Group Berhad은 연간 수입과 매출이 각각 9.6%와 4% 증가할 것으로 예상되고 EPS는 연간 9.1%만큼 증가할 것으로 예상됩니다.핵심 정보9.6%이익 성장률9.07%EPS 성장률Personal Products 이익 성장14.9%매출 성장률4.0%향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트21 May 2026최근 향후 성장 업데이트Major Estimate Revision • May 28Consensus EPS estimates fall by 19%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate fell from RM0.036 to RM0.029. Revenue forecast unchanged from RM47.8m at last update. Net income forecast to grow 15% next year vs 20% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.47 to RM0.38. Share price fell 2.9% to RM0.33 over the past week.Price Target Changed • May 21Price target decreased by 22% to RM0.38Down from RM0.48, the current price target is provided by 1 analyst. New target price is 12% above last closing price of RM0.34. Stock is up 13% over the past year. The company is forecast to post earnings per share of RM0.029 for next year compared to RM0.024 last year.Price Target Changed • Sep 02Price target decreased by 9.5% to RM0.60Down from RM0.66, the current price target is an average from 3 analysts. New target price is 33% above last closing price of RM0.45. Stock is down 38% over the past year. The company is forecast to post earnings per share of RM0.041 for next year compared to RM0.025 last year.Major Estimate Revision • May 28Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from RM45.8m to RM44.7m. EPS estimate also fell from RM0.046 per share to RM0.04 per share. Net income forecast to grow 34% next year vs 24% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.66 to RM0.64. Share price fell 12% to RM0.54 over the past week.Major Estimate Revision • Nov 13Consensus revenue estimates fall by 12%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from RM54.1m to RM47.7m. EPS estimate fell from RM0.058 to RM0.049 per share. Net income forecast to grow 19% next year vs 27% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.84 to RM0.70. Share price fell 7.5% to RM0.68 over the past week.Price Target Changed • Jun 01Price target decreased by 14% to RM0.84Down from RM0.99, the current price target is an average from 2 analysts. New target price is 14% above last closing price of RM0.74. Stock is down 18% over the past year. The company is forecast to post earnings per share of RM0.046 for next year compared to RM0.051 last year.모든 업데이트 보기Recent updatesMajor Estimate Revision • May 28Consensus EPS estimates fall by 19%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate fell from RM0.036 to RM0.029. Revenue forecast unchanged from RM47.8m at last update. Net income forecast to grow 15% next year vs 20% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.47 to RM0.38. Share price fell 2.9% to RM0.33 over the past week.Reported Earnings • May 22Third quarter 2026 earnings released: EPS: RM0.006 (vs RM0.009 in 3Q 2025)Third quarter 2026 results: EPS: RM0.006 (down from RM0.009 in 3Q 2025). Revenue: RM13.0m (up 9.9% from 3Q 2025). Net income: RM2.03m (down 31% from 3Q 2025). Profit margin: 16% (down from 25% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.0% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 24% per year.Price Target Changed • May 21Price target decreased by 22% to RM0.38Down from RM0.48, the current price target is provided by 1 analyst. New target price is 12% above last closing price of RM0.34. Stock is up 13% over the past year. The company is forecast to post earnings per share of RM0.029 for next year compared to RM0.024 last year.Board Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. No experienced directors. 7 highly experienced directors. Independent & Non-Executive Director Muhammad Bin Abu Hassan was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.분석 기사 • Nov 06Capital Allocation Trends At Nova Wellness Group Berhad (KLSE:NOVA) Aren't IdealTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...공시 • Oct 15Nova Wellness Group Berhad, Annual General Meeting, Nov 19, 2025Nova Wellness Group Berhad, Annual General Meeting, Nov 19, 2025, at 10:00 Singapore Standard Time. Location: ballroom, ibis styles sepang klia, jalan klia 1/60, 43900 sepang, selangor darul ehsan, Malaysia분석 기사 • Jul 08Take Care Before Diving Into The Deep End On Nova Wellness Group Berhad (KLSE:NOVA)There wouldn't be many who think Nova Wellness Group Berhad's ( KLSE:NOVA ) price-to-earnings (or "P/E") ratio of 15.5x...분석 기사 • May 29Returns On Capital At Nova Wellness Group Berhad (KLSE:NOVA) Paint A Concerning PictureThere are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...Board Change • Mar 14Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. Independent Non-Executive Chairman Abdul bin Mohamad Radzi was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.분석 기사 • Feb 28Why Investors Shouldn't Be Surprised By Nova Wellness Group Berhad's (KLSE:NOVA) P/EWith a price-to-earnings (or "P/E") ratio of 18.2x Nova Wellness Group Berhad ( KLSE:NOVA ) may be sending bearish...Upcoming Dividend • Nov 15Upcoming dividend of RM0.013 per shareEligible shareholders must have bought the stock before 22 November 2024. Payment date: 10 December 2024. Payout ratio is a comfortable 51% but the company is paying out more than the cash it is generating. Trailing yield: 2.7%. Lower than top quartile of Malaysian dividend payers (4.8%). Higher than average of industry peers (2.0%).Reported Earnings • Oct 20Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: RM0.025 (down from RM0.047 in FY 2023). Revenue: RM40.8m (down 10% from FY 2023). Net income: RM7.87m (down 48% from FY 2023). Profit margin: 19% (down from 33% in FY 2023). The decrease in margin was primarily driven by lower revenue. Revenue missed analyst estimates by 8.7%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 20% per year.공시 • Oct 16+ 1 more updateNova Wellness Group Berhad, Annual General Meeting, Nov 19, 2024Nova Wellness Group Berhad, Annual General Meeting, Nov 19, 2024, at 10:00 Singapore Standard Time. Location: ballroom, ibis styles sepang klia, jalan klia 1/60, 43900 sepang, selangor darul ehsan, Malaysia분석 기사 • Sep 03The Returns On Capital At Nova Wellness Group Berhad (KLSE:NOVA) Don't Inspire ConfidenceWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Price Target Changed • Sep 02Price target decreased by 9.5% to RM0.60Down from RM0.66, the current price target is an average from 3 analysts. New target price is 33% above last closing price of RM0.45. Stock is down 38% over the past year. The company is forecast to post earnings per share of RM0.041 for next year compared to RM0.025 last year.New Risk • Aug 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 19% Last year net profit margin: 33% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (192% cash payout ratio). Profit margins are more than 30% lower than last year (19% net profit margin). Market cap is less than US$100m (RM157.8m market cap, or US$36.5m).Major Estimate Revision • May 28Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from RM45.8m to RM44.7m. EPS estimate also fell from RM0.046 per share to RM0.04 per share. Net income forecast to grow 34% next year vs 24% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.66 to RM0.64. Share price fell 12% to RM0.54 over the past week.Reported Earnings • May 22Third quarter 2024 earnings released: EPS: RM0.006 (vs RM0.009 in 3Q 2023)Third quarter 2024 results: EPS: RM0.006 (down from RM0.009 in 3Q 2023). Revenue: RM10.1m (down 8.7% from 3Q 2023). Net income: RM1.84m (down 37% from 3Q 2023). Profit margin: 18% (down from 27% in 3Q 2023). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has fallen by 11% per year and the company’s share price has also fallen by 11% per year.Reported Earnings • Feb 21Second quarter 2024 earnings released: EPS: RM0.01 (vs RM0.013 in 2Q 2023)Second quarter 2024 results: EPS: RM0.01 (down from RM0.013 in 2Q 2023). Revenue: RM10.2m (down 15% from 2Q 2023). Net income: RM3.06m (down 28% from 2Q 2023). Profit margin: 30% (down from 36% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings.분석 기사 • Feb 20Not Many Are Piling Into Nova Wellness Group Berhad (KLSE:NOVA) Just YetWhen close to half the companies in Malaysia have price-to-earnings ratios (or "P/E's") above 16x, you may consider...Upcoming Dividend • Nov 23Upcoming dividend of RM0.013 per share at 5.1% yieldEligible shareholders must have bought the stock before 30 November 2023. Payment date: 08 December 2023. Payout ratio is a comfortable 50% but the company is paying out more than the cash it is generating. Trailing yield: 5.1%. Within top quartile of Malaysian dividend payers (5.0%). Higher than average of industry peers (1.7%).Major Estimate Revision • Nov 13Consensus revenue estimates fall by 12%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from RM54.1m to RM47.7m. EPS estimate fell from RM0.058 to RM0.049 per share. Net income forecast to grow 19% next year vs 27% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.84 to RM0.70. Share price fell 7.5% to RM0.68 over the past week.분석 기사 • Nov 07Nova Wellness Group Berhad (KLSE:NOVA) Has Affirmed Its Dividend Of MYR0.0125Nova Wellness Group Berhad's ( KLSE:NOVA ) investors are due to receive a payment of MYR0.0125 per share on 8th of...공시 • Nov 07Nova Wellness Group Berhad Approves Final Single Tier Dividend for the Financial Year Ended 30 June 2023Nova Wellness Group Berhad at the AGM held on 6 November 2023 approved to declare a final single tier dividend of 1.25 sen per share for the financial year ended 30 June 2023 as recommended by the Directors.분석 기사 • Oct 12Nova Wellness Group Berhad (KLSE:NOVA) Will Pay A Dividend Of MYR0.0125Nova Wellness Group Berhad's ( KLSE:NOVA ) investors are due to receive a payment of MYR0.0125 per share on 8th of...Reported Earnings • Oct 12Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2023 results: EPS: RM0.047 (down from RM0.051 in FY 2022). Revenue: RM45.5m (down 7.3% from FY 2022). Net income: RM15.0m (down 6.9% from FY 2022). Profit margin: 33% (in line with FY 2022). Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst estimates by 1.5%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 9.2% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.공시 • Oct 06Nova Wellness Group Berhad, Annual General Meeting, Nov 06, 2023Nova Wellness Group Berhad, Annual General Meeting, Nov 06, 2023, at 10:00 Singapore Standard Time. Location: Dewan Utama 1, Hotel Seri Malaysia, Lot 979 & 980; Pantai Bagan Lalang 43950 Sungai Pelek, Sepang SELANGOR DARUL EHSAN Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 30 June 2023 and the Reports of the Directors and Auditors thereon; to declare a Final Single Tier Dividend of 1.25 sen per share for the financial year ended 30 June 2023 as recommended by the Directors; to re-elect Sulaiman Bin Haji Ahmad who is retiring under Clause 109 of the Constitution of the Company; to consider Proposed Directors' Fees for the period from the date of forthcoming Annual General Meeting until the next Annual General Meeting in year 2024; and to consider other matters.공시 • Sep 29Nova Wellness Group Berhad Recommends Final Single Tier Dividend in Respect of the Financial Year Ended 30 June 2023Nova Wellness Group Berhad announced the recommendation for the declaration and payment of a final single tier dividend of 1.25 sen per ordinary share in respect of the financial year ended 30 June 2023, which is subject to the approval of the shareholders of the Company at its forthcoming Annual General Meeting. The date of entitlement and date of payment in respect of the aforesaid dividend will be announced in due course.New Risk • Aug 21New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (RM229.5m market cap, or US$49.4m).Reported Earnings • Aug 19Full year 2023 earnings released: EPS: RM0.047 (vs RM0.051 in FY 2022)Full year 2023 results: EPS: RM0.047 (down from RM0.051 in FY 2022). Revenue: RM45.5m (down 7.3% from FY 2022). Net income: RM15.0m (down 6.8% from FY 2022). Profit margin: 33% (in line with FY 2022). Revenue is forecast to grow 8.1% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.공시 • Aug 19+ 1 more updateNova Wellness Group Berhad Appoints Wong Mee Kiat as Company SecretaryNova Wellness Group Berhad announced the appointment of Wong Mee Kiat as Company Secretary, effective from 18 August 2023.Price Target Changed • Jun 01Price target decreased by 14% to RM0.84Down from RM0.99, the current price target is an average from 2 analysts. New target price is 14% above last closing price of RM0.74. Stock is down 18% over the past year. The company is forecast to post earnings per share of RM0.046 for next year compared to RM0.051 last year.Major Estimate Revision • May 30Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from RM55.9m to RM53.0m. EPS estimate also fell from RM0.061 per share to RM0.054 per share. Net income forecast to grow 51% next year vs 31% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.99 to RM0.93. Share price fell 12% to RM0.76 over the past week.Reported Earnings • May 24Third quarter 2023 earnings released: EPS: RM0.009 (vs RM0.015 in 3Q 2022)Third quarter 2023 results: EPS: RM0.009 (down from RM0.015 in 3Q 2022). Revenue: RM11.0m (down 8.0% from 3Q 2022). Net income: RM2.94m (down 40% from 3Q 2022). Profit margin: 27% (down from 41% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 2% per year.Upcoming Dividend • Mar 01Upcoming dividend of RM0.021 per share at 3.7% yieldEligible shareholders must have bought the stock before 08 March 2023. Payment date: 16 March 2023. Payout ratio is a comfortable 44% but the company is not cash flow positive. Trailing yield: 3.7%. Lower than top quartile of Malaysian dividend payers (5.2%). Higher than average of industry peers (1.6%).분석 기사 • Feb 23Nova Wellness Group Berhad (KLSE:NOVA) Is Increasing Its Dividend To MYR0.0205The board of Nova Wellness Group Berhad ( KLSE:NOVA ) has announced that the dividend on 16th of March will be...Reported Earnings • Feb 22Second quarter 2023 earnings released: EPS: RM1.35 (vs RM0.014 in 2Q 2022)Second quarter 2023 results: EPS: RM1.35. Revenue: RM12.0m (flat on 2Q 2022). Net income: RM4.28m (down 3.0% from 2Q 2022). Profit margin: 36% (in line with 2Q 2022). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in Asia.분석 기사 • Nov 25Nova Wellness Group Berhad's (KLSE:NOVA) Shareholders Will Receive A Bigger Dividend Than Last YearNova Wellness Group Berhad's ( KLSE:NOVA ) periodic dividend will be increasing on the 8th of December to MYR0.0125...공시 • Nov 23Nova Wellness Group Berhad Announces Final Dividend for the Financial Year Ended June 30, 2022, Payable on December 8, 2022Nova Wellness Group Berhad announced final dividend of MYR 0.125 per ordinary share for the financial year ended June 30, 2022 with ex-date as November 30, 2022, entitlement date as December 1, 2022 and Payment date as December 8, 2022.Reported Earnings • Nov 17First quarter 2023 earnings released: EPS: RM0.013 (vs RM0.016 in 1Q 2022)First quarter 2023 results: EPS: RM0.013 (down from RM0.016 in 1Q 2022). Revenue: RM12.0m (down 17% from 1Q 2022). Net income: RM4.27m (down 18% from 1Q 2022). Profit margin: 36% (in line with 1Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 13% per year.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. Independent & Non-Executive Chairman Abdul bin Mohamad Radzi was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 21Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: RM0.051 (up from RM0.046 in FY 2021). Revenue: RM49.1m (up 21% from FY 2021). Net income: RM16.1m (up 11% from FY 2021). Profit margin: 33% (down from 36% in FY 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 11% per year.분석 기사 • Aug 30At RM0.86, Is It Time To Put Nova Wellness Group Berhad (KLSE:NOVA) On Your Watch List?While Nova Wellness Group Berhad ( KLSE:NOVA ) might not be the most widely known stock at the moment, it saw...Reported Earnings • Aug 26Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: RM0.05 (up from RM0.046 in FY 2021). Revenue: RM49.1m (up 21% from FY 2021). Net income: RM15.9m (up 9.4% from FY 2021). Profit margin: 32% (down from 36% in FY 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 100%. Earnings per share (EPS) also missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 18%, compared to a 11% growth forecast for the Personal Products industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 23% per year, which means it is tracking significantly ahead of earnings growth.공시 • Aug 26Nova Wellness Group Berhad Proposes Single Tier Tax Exempted Final Dividend in Respect of the Financial Year Ended 30 June 2022Nova Wellness Group Berhad announced the recommendation for the declaration and payment of a single tier tax exempted final dividend of 1.25 sen per ordinary share in respect of the financial year ended 30 June 2022, which is subject to the approval of the shareholders of the Company at its forthcoming Annual General Meeting.분석 기사 • Jul 22Should You Be Adding Nova Wellness Group Berhad (KLSE:NOVA) To Your Watchlist Today?The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Reported Earnings • May 25Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindThird quarter 2022 results: EPS: RM0.015 (up from RM0.011 in 3Q 2021). Revenue: RM12.0m (up 18% from 3Q 2021). Net income: RM4.88m (up 41% from 3Q 2021). Profit margin: 41% (up from 34% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 8.8%. Earnings per share (EPS) missed analyst estimates by 2.6%. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Non Independent & Non Executive Director Seng Loong Sim was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Mar 01Upcoming dividend of RM0.02 per shareEligible shareholders must have bought the stock before 08 March 2022. Payment date: 16 March 2022. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 2.0%. Lower than top quartile of Malaysian dividend payers (4.5%). Higher than average of industry peers (1.6%).Reported Earnings • Feb 24Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2022 results: EPS: RM0.014 (up from RM0.013 in 2Q 2021). Revenue: RM12.1m (up 21% from 2Q 2021). Net income: RM4.41m (up 8.8% from 2Q 2021). Profit margin: 37% (down from 41% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 8.8%. Earnings per share (EPS) missed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 1.8%, compared to a 11% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 25% per year.공시 • Feb 24+ 1 more updateNova Wellness Group Berhad Announces Single Tier Tax Exempted Special Dividend for the Financial Year Ending 30 June 2022The Board of Directors of Nova Wellness Group Berhad announced the declaration of a single tier tax exempted interim dividend of 0.8 sen per ordinary share and a single tier tax exempted special dividend of 1.2 sen per ordinary share in respect of the financial year ending 30 June 2022.Upcoming Dividend • Nov 23Upcoming dividend of RM0.012 per shareEligible shareholders must have bought the stock before 30 November 2021. Payment date: 08 December 2021. Trailing yield: 1.8%. Lower than top quartile of Malaysian dividend payers (4.2%). Higher than average of industry peers (1.5%).Reported Earnings • Oct 21Full year 2021 earnings released: EPS RM0.046 (vs RM0.041 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: RM40.5m (up 18% from FY 2020). Net income: RM14.6m (up 12% from FY 2020). Profit margin: 36% (down from 38% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.분석 기사 • Oct 17Nova Wellness Group Berhad's (KLSE:NOVA) Shareholders Will Receive A Bigger Dividend Than Last YearThe board of Nova Wellness Group Berhad ( KLSE:NOVA ) has announced that it will be increasing its dividend on the 8th...Board Change • Oct 12Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Non Independent & Non Executive Director Seng Loong Sim was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Jul 15Nova Laboratories Sdn. Bhd Announces Temporary Closure of Its OperationThe Board of Directors of Nova Wellness Group Berhad announce that Nova Laboratories Sdn. Bhd., a subsidiary of the Company, is implementing a temporary closure of its operation for 7 days from 12 July 2021 to 18 July 2021 according to the guidance from the Ministry of Health (MOH). The Company had discovered several positive cases of COVID-19 infection among its factory workers. The employees who have tested positive are currently placed under quarantine and isolation. The temporary closure is not expected to have a significant impact on the financial performance of Nova Group. However, it is expected to result in the minor deferment of shipment to its customers throughout the temporary closure period. The Group will take the following actions: Conduct sanitisation work in its factory; Conduct COVID-19 test for workers that had been in close contact with those that were tested COVID-19 positive via contact tracing; and Implement quarantine measures for the affected workers and close contacts in adherence to advice from the MOH.Executive Departure • May 27Independent & Non-Executive Chairman Abdul bin Mohamad Radzi has left the companyOn the 18th of May, Abdul bin Mohamad Radzi's tenure as Independent & Non-Executive Chairman ended after 3.5 years in the role. As of March 2021, Abdul personally held 520.00k shares (RM234k worth at the time). A total of 2 executives have left over the last 12 months.Reported Earnings • May 20Third quarter 2021 earnings released: EPS RM0.011 (vs RM0.009 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: RM10.2m (up 16% from 3Q 2020). Net income: RM3.46m (up 27% from 3Q 2020). Profit margin: 34% (up from 31% in 3Q 2020). The increase in margin was driven by higher revenue.분석 기사 • Mar 28Are Dividend Investors Making A Mistake With Nova Wellness Group Berhad (KLSE:NOVA)?Could Nova Wellness Group Berhad ( KLSE:NOVA ) be an attractive dividend share to own for the long haul? Investors are...분석 기사 • Mar 10With EPS Growth And More, Nova Wellness Group Berhad (KLSE:NOVA) Is InterestingIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...Is New 90 Day High Low • Mar 05New 90-day low: RM0.85The company is down 10.0% from its price of RM0.94 on 04 December 2020. The Malaysian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 1.0% over the same period.분석 기사 • Feb 20Dividend Investors: Don't Be Too Quick To Buy Nova Wellness Group Berhad (KLSE:NOVA) For Its Upcoming DividendNova Wellness Group Berhad ( KLSE:NOVA ) is about to trade ex-dividend in the next three days. You will need to...Reported Earnings • Feb 12Second quarter 2021 earnings released: EPS RM0.013 (vs RM0.011 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: RM10.0m (up 13% from 2Q 2020). Net income: RM4.06m (up 14% from 2Q 2020). Profit margin: 41% (in line with 2Q 2020).분석 기사 • Feb 05Declining Stock and Decent Financials: Is The Market Wrong About Nova Wellness Group Berhad (KLSE:NOVA)?It is hard to get excited after looking at Nova Wellness Group Berhad's (KLSE:NOVA) recent performance, when its stock...분석 기사 • Jan 19Did Nova Wellness Group Berhad's (KLSE:NOVA) Share Price Deserve to Gain 79%?If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...공시 • Jan 08+ 1 more updateNova Wellness Group Berhad Announces Demise of Munavvar Zubaid Bin Abdul Sattar, Member of Remuneration CommitteeNova Wellness Group Berhad announced Demise of MUNAVVAR ZUBAID BIN ABDUL SATTAR, Member of Remuneration Committee. Date of change is 06 January 2021.분석 기사 • Jan 01Has Nova Wellness Group Berhad (KLSE:NOVA) Got What It Takes To Become A Multi-Bagger?Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Is New 90 Day High Low • Dec 31New 90-day low: RM0.86The company is down 5.0% from its price of RM0.92 on 02 October 2020. The Malaysian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 8.0% over the same period.분석 기사 • Dec 14Key Things To Watch Out For If You Are After Nova Wellness Group Berhad's (KLSE:NOVA) 1.6% DividendCould Nova Wellness Group Berhad ( KLSE:NOVA ) be an attractive dividend share to own for the long haul? Investors are...분석 기사 • Nov 26Nova Wellness Group Berhad (KLSE:NOVA) Stock Goes Ex-Dividend In Just Four DaysSome investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...분석 기사 • Nov 20With EPS Growth And More, Nova Wellness Group Berhad (KLSE:NOVA) Is InterestingLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...Reported Earnings • Nov 17First quarter 2021 earnings released: EPS RM0.009The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: RM9.05m (up 51% from 1Q 2020). Net income: RM2.69m (up 45% from 1Q 2020). Profit margin: 30% (down from 31% in 1Q 2020). The decrease in margin was driven by higher expenses.Reported Earnings • Oct 21Full year earnings released - EPS RM0.041Over the last 12 months the company has reported total profits of RM13.0m, up 19% from the prior year. Total revenue was RM34.3m over the last 12 months, up 15% from the prior year. Profit margins were 38%, which is higher than the 37% margin from last year. The increase in margin was driven by higher revenue.이익 및 매출 성장 예측KLSE:NOVA - 애널리스트 향후 추정치 및 과거 재무 데이터 (MYR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수6/30/20275010N/AN/A16/30/2026489N/AN/A13/31/20264781215N/A12/31/20254691214N/A9/30/2025469811N/A6/30/202544816N/A3/31/2025447-4-1N/A12/31/2024426-22N/A9/30/202441726N/A6/30/202441847N/A3/31/20244111913N/A12/31/20234212913N/A9/30/20234413312N/A6/30/20234615-29N/A3/31/20234613-79N/A12/31/20224715-611N/A9/30/20224715-48N/A6/30/20224916212N/A3/31/20225019611N/A12/31/2021481727N/A9/30/2021461716N/A6/30/2021401539N/A3/31/2021401529N/A12/31/20203914411N/A9/30/20203714412N/A6/30/20203413110N/A3/31/20203313311N/A12/31/20193212N/A12N/A9/30/20193112N/A10N/A6/30/20193011N/A12N/A3/31/2019289N/A12N/A12/31/2018268N/A9N/A9/30/2018247N/A10N/A6/30/2018258N/A7N/A3/31/2018239N/A9N/A12/31/20172411N/A14N/A9/30/20172412N/A13N/A6/30/20172514N/A11N/A6/30/20162414N/A15N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: NOVA 의 연간 예상 수익 증가율(9.6%)이 saving rate(3.8%)보다 높습니다.수익 vs 시장: NOVA 의 연간 수익(9.6%)이 MY 시장(9%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: NOVA 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: NOVA 의 수익(연간 4%)이 MY 시장(연간 6.9%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: NOVA 의 수익(연간 4%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: NOVA의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YHousehold 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/06 21:08종가2026/07/06 00:00수익2026/03/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Nova Wellness Group Berhad는 5명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관null nullBIMB Securities Sdn. BhdPing-Khoon ChooKenanga Researchnull nullMercury Securities Sdn. Bhd2명의 분석가 더 보기
Major Estimate Revision • May 28Consensus EPS estimates fall by 19%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate fell from RM0.036 to RM0.029. Revenue forecast unchanged from RM47.8m at last update. Net income forecast to grow 15% next year vs 20% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.47 to RM0.38. Share price fell 2.9% to RM0.33 over the past week.
Price Target Changed • May 21Price target decreased by 22% to RM0.38Down from RM0.48, the current price target is provided by 1 analyst. New target price is 12% above last closing price of RM0.34. Stock is up 13% over the past year. The company is forecast to post earnings per share of RM0.029 for next year compared to RM0.024 last year.
Price Target Changed • Sep 02Price target decreased by 9.5% to RM0.60Down from RM0.66, the current price target is an average from 3 analysts. New target price is 33% above last closing price of RM0.45. Stock is down 38% over the past year. The company is forecast to post earnings per share of RM0.041 for next year compared to RM0.025 last year.
Major Estimate Revision • May 28Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from RM45.8m to RM44.7m. EPS estimate also fell from RM0.046 per share to RM0.04 per share. Net income forecast to grow 34% next year vs 24% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.66 to RM0.64. Share price fell 12% to RM0.54 over the past week.
Major Estimate Revision • Nov 13Consensus revenue estimates fall by 12%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from RM54.1m to RM47.7m. EPS estimate fell from RM0.058 to RM0.049 per share. Net income forecast to grow 19% next year vs 27% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.84 to RM0.70. Share price fell 7.5% to RM0.68 over the past week.
Price Target Changed • Jun 01Price target decreased by 14% to RM0.84Down from RM0.99, the current price target is an average from 2 analysts. New target price is 14% above last closing price of RM0.74. Stock is down 18% over the past year. The company is forecast to post earnings per share of RM0.046 for next year compared to RM0.051 last year.
Major Estimate Revision • May 28Consensus EPS estimates fall by 19%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate fell from RM0.036 to RM0.029. Revenue forecast unchanged from RM47.8m at last update. Net income forecast to grow 15% next year vs 20% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.47 to RM0.38. Share price fell 2.9% to RM0.33 over the past week.
Reported Earnings • May 22Third quarter 2026 earnings released: EPS: RM0.006 (vs RM0.009 in 3Q 2025)Third quarter 2026 results: EPS: RM0.006 (down from RM0.009 in 3Q 2025). Revenue: RM13.0m (up 9.9% from 3Q 2025). Net income: RM2.03m (down 31% from 3Q 2025). Profit margin: 16% (down from 25% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.0% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 24% per year.
Price Target Changed • May 21Price target decreased by 22% to RM0.38Down from RM0.48, the current price target is provided by 1 analyst. New target price is 12% above last closing price of RM0.34. Stock is up 13% over the past year. The company is forecast to post earnings per share of RM0.029 for next year compared to RM0.024 last year.
Board Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. No experienced directors. 7 highly experienced directors. Independent & Non-Executive Director Muhammad Bin Abu Hassan was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
분석 기사 • Nov 06Capital Allocation Trends At Nova Wellness Group Berhad (KLSE:NOVA) Aren't IdealTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
공시 • Oct 15Nova Wellness Group Berhad, Annual General Meeting, Nov 19, 2025Nova Wellness Group Berhad, Annual General Meeting, Nov 19, 2025, at 10:00 Singapore Standard Time. Location: ballroom, ibis styles sepang klia, jalan klia 1/60, 43900 sepang, selangor darul ehsan, Malaysia
분석 기사 • Jul 08Take Care Before Diving Into The Deep End On Nova Wellness Group Berhad (KLSE:NOVA)There wouldn't be many who think Nova Wellness Group Berhad's ( KLSE:NOVA ) price-to-earnings (or "P/E") ratio of 15.5x...
분석 기사 • May 29Returns On Capital At Nova Wellness Group Berhad (KLSE:NOVA) Paint A Concerning PictureThere are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...
Board Change • Mar 14Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. Independent Non-Executive Chairman Abdul bin Mohamad Radzi was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
분석 기사 • Feb 28Why Investors Shouldn't Be Surprised By Nova Wellness Group Berhad's (KLSE:NOVA) P/EWith a price-to-earnings (or "P/E") ratio of 18.2x Nova Wellness Group Berhad ( KLSE:NOVA ) may be sending bearish...
Upcoming Dividend • Nov 15Upcoming dividend of RM0.013 per shareEligible shareholders must have bought the stock before 22 November 2024. Payment date: 10 December 2024. Payout ratio is a comfortable 51% but the company is paying out more than the cash it is generating. Trailing yield: 2.7%. Lower than top quartile of Malaysian dividend payers (4.8%). Higher than average of industry peers (2.0%).
Reported Earnings • Oct 20Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: RM0.025 (down from RM0.047 in FY 2023). Revenue: RM40.8m (down 10% from FY 2023). Net income: RM7.87m (down 48% from FY 2023). Profit margin: 19% (down from 33% in FY 2023). The decrease in margin was primarily driven by lower revenue. Revenue missed analyst estimates by 8.7%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 20% per year.
공시 • Oct 16+ 1 more updateNova Wellness Group Berhad, Annual General Meeting, Nov 19, 2024Nova Wellness Group Berhad, Annual General Meeting, Nov 19, 2024, at 10:00 Singapore Standard Time. Location: ballroom, ibis styles sepang klia, jalan klia 1/60, 43900 sepang, selangor darul ehsan, Malaysia
분석 기사 • Sep 03The Returns On Capital At Nova Wellness Group Berhad (KLSE:NOVA) Don't Inspire ConfidenceWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Price Target Changed • Sep 02Price target decreased by 9.5% to RM0.60Down from RM0.66, the current price target is an average from 3 analysts. New target price is 33% above last closing price of RM0.45. Stock is down 38% over the past year. The company is forecast to post earnings per share of RM0.041 for next year compared to RM0.025 last year.
New Risk • Aug 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 19% Last year net profit margin: 33% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (192% cash payout ratio). Profit margins are more than 30% lower than last year (19% net profit margin). Market cap is less than US$100m (RM157.8m market cap, or US$36.5m).
Major Estimate Revision • May 28Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from RM45.8m to RM44.7m. EPS estimate also fell from RM0.046 per share to RM0.04 per share. Net income forecast to grow 34% next year vs 24% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.66 to RM0.64. Share price fell 12% to RM0.54 over the past week.
Reported Earnings • May 22Third quarter 2024 earnings released: EPS: RM0.006 (vs RM0.009 in 3Q 2023)Third quarter 2024 results: EPS: RM0.006 (down from RM0.009 in 3Q 2023). Revenue: RM10.1m (down 8.7% from 3Q 2023). Net income: RM1.84m (down 37% from 3Q 2023). Profit margin: 18% (down from 27% in 3Q 2023). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has fallen by 11% per year and the company’s share price has also fallen by 11% per year.
Reported Earnings • Feb 21Second quarter 2024 earnings released: EPS: RM0.01 (vs RM0.013 in 2Q 2023)Second quarter 2024 results: EPS: RM0.01 (down from RM0.013 in 2Q 2023). Revenue: RM10.2m (down 15% from 2Q 2023). Net income: RM3.06m (down 28% from 2Q 2023). Profit margin: 30% (down from 36% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings.
분석 기사 • Feb 20Not Many Are Piling Into Nova Wellness Group Berhad (KLSE:NOVA) Just YetWhen close to half the companies in Malaysia have price-to-earnings ratios (or "P/E's") above 16x, you may consider...
Upcoming Dividend • Nov 23Upcoming dividend of RM0.013 per share at 5.1% yieldEligible shareholders must have bought the stock before 30 November 2023. Payment date: 08 December 2023. Payout ratio is a comfortable 50% but the company is paying out more than the cash it is generating. Trailing yield: 5.1%. Within top quartile of Malaysian dividend payers (5.0%). Higher than average of industry peers (1.7%).
Major Estimate Revision • Nov 13Consensus revenue estimates fall by 12%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from RM54.1m to RM47.7m. EPS estimate fell from RM0.058 to RM0.049 per share. Net income forecast to grow 19% next year vs 27% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.84 to RM0.70. Share price fell 7.5% to RM0.68 over the past week.
분석 기사 • Nov 07Nova Wellness Group Berhad (KLSE:NOVA) Has Affirmed Its Dividend Of MYR0.0125Nova Wellness Group Berhad's ( KLSE:NOVA ) investors are due to receive a payment of MYR0.0125 per share on 8th of...
공시 • Nov 07Nova Wellness Group Berhad Approves Final Single Tier Dividend for the Financial Year Ended 30 June 2023Nova Wellness Group Berhad at the AGM held on 6 November 2023 approved to declare a final single tier dividend of 1.25 sen per share for the financial year ended 30 June 2023 as recommended by the Directors.
분석 기사 • Oct 12Nova Wellness Group Berhad (KLSE:NOVA) Will Pay A Dividend Of MYR0.0125Nova Wellness Group Berhad's ( KLSE:NOVA ) investors are due to receive a payment of MYR0.0125 per share on 8th of...
Reported Earnings • Oct 12Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2023 results: EPS: RM0.047 (down from RM0.051 in FY 2022). Revenue: RM45.5m (down 7.3% from FY 2022). Net income: RM15.0m (down 6.9% from FY 2022). Profit margin: 33% (in line with FY 2022). Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst estimates by 1.5%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 9.2% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
공시 • Oct 06Nova Wellness Group Berhad, Annual General Meeting, Nov 06, 2023Nova Wellness Group Berhad, Annual General Meeting, Nov 06, 2023, at 10:00 Singapore Standard Time. Location: Dewan Utama 1, Hotel Seri Malaysia, Lot 979 & 980; Pantai Bagan Lalang 43950 Sungai Pelek, Sepang SELANGOR DARUL EHSAN Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 30 June 2023 and the Reports of the Directors and Auditors thereon; to declare a Final Single Tier Dividend of 1.25 sen per share for the financial year ended 30 June 2023 as recommended by the Directors; to re-elect Sulaiman Bin Haji Ahmad who is retiring under Clause 109 of the Constitution of the Company; to consider Proposed Directors' Fees for the period from the date of forthcoming Annual General Meeting until the next Annual General Meeting in year 2024; and to consider other matters.
공시 • Sep 29Nova Wellness Group Berhad Recommends Final Single Tier Dividend in Respect of the Financial Year Ended 30 June 2023Nova Wellness Group Berhad announced the recommendation for the declaration and payment of a final single tier dividend of 1.25 sen per ordinary share in respect of the financial year ended 30 June 2023, which is subject to the approval of the shareholders of the Company at its forthcoming Annual General Meeting. The date of entitlement and date of payment in respect of the aforesaid dividend will be announced in due course.
New Risk • Aug 21New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (RM229.5m market cap, or US$49.4m).
Reported Earnings • Aug 19Full year 2023 earnings released: EPS: RM0.047 (vs RM0.051 in FY 2022)Full year 2023 results: EPS: RM0.047 (down from RM0.051 in FY 2022). Revenue: RM45.5m (down 7.3% from FY 2022). Net income: RM15.0m (down 6.8% from FY 2022). Profit margin: 33% (in line with FY 2022). Revenue is forecast to grow 8.1% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
공시 • Aug 19+ 1 more updateNova Wellness Group Berhad Appoints Wong Mee Kiat as Company SecretaryNova Wellness Group Berhad announced the appointment of Wong Mee Kiat as Company Secretary, effective from 18 August 2023.
Price Target Changed • Jun 01Price target decreased by 14% to RM0.84Down from RM0.99, the current price target is an average from 2 analysts. New target price is 14% above last closing price of RM0.74. Stock is down 18% over the past year. The company is forecast to post earnings per share of RM0.046 for next year compared to RM0.051 last year.
Major Estimate Revision • May 30Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from RM55.9m to RM53.0m. EPS estimate also fell from RM0.061 per share to RM0.054 per share. Net income forecast to grow 51% next year vs 31% growth forecast for Personal Products industry in Malaysia. Consensus price target down from RM0.99 to RM0.93. Share price fell 12% to RM0.76 over the past week.
Reported Earnings • May 24Third quarter 2023 earnings released: EPS: RM0.009 (vs RM0.015 in 3Q 2022)Third quarter 2023 results: EPS: RM0.009 (down from RM0.015 in 3Q 2022). Revenue: RM11.0m (down 8.0% from 3Q 2022). Net income: RM2.94m (down 40% from 3Q 2022). Profit margin: 27% (down from 41% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 2% per year.
Upcoming Dividend • Mar 01Upcoming dividend of RM0.021 per share at 3.7% yieldEligible shareholders must have bought the stock before 08 March 2023. Payment date: 16 March 2023. Payout ratio is a comfortable 44% but the company is not cash flow positive. Trailing yield: 3.7%. Lower than top quartile of Malaysian dividend payers (5.2%). Higher than average of industry peers (1.6%).
분석 기사 • Feb 23Nova Wellness Group Berhad (KLSE:NOVA) Is Increasing Its Dividend To MYR0.0205The board of Nova Wellness Group Berhad ( KLSE:NOVA ) has announced that the dividend on 16th of March will be...
Reported Earnings • Feb 22Second quarter 2023 earnings released: EPS: RM1.35 (vs RM0.014 in 2Q 2022)Second quarter 2023 results: EPS: RM1.35. Revenue: RM12.0m (flat on 2Q 2022). Net income: RM4.28m (down 3.0% from 2Q 2022). Profit margin: 36% (in line with 2Q 2022). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in Asia.
분석 기사 • Nov 25Nova Wellness Group Berhad's (KLSE:NOVA) Shareholders Will Receive A Bigger Dividend Than Last YearNova Wellness Group Berhad's ( KLSE:NOVA ) periodic dividend will be increasing on the 8th of December to MYR0.0125...
공시 • Nov 23Nova Wellness Group Berhad Announces Final Dividend for the Financial Year Ended June 30, 2022, Payable on December 8, 2022Nova Wellness Group Berhad announced final dividend of MYR 0.125 per ordinary share for the financial year ended June 30, 2022 with ex-date as November 30, 2022, entitlement date as December 1, 2022 and Payment date as December 8, 2022.
Reported Earnings • Nov 17First quarter 2023 earnings released: EPS: RM0.013 (vs RM0.016 in 1Q 2022)First quarter 2023 results: EPS: RM0.013 (down from RM0.016 in 1Q 2022). Revenue: RM12.0m (down 17% from 1Q 2022). Net income: RM4.27m (down 18% from 1Q 2022). Profit margin: 36% (in line with 1Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 13% per year.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. Independent & Non-Executive Chairman Abdul bin Mohamad Radzi was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 21Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: RM0.051 (up from RM0.046 in FY 2021). Revenue: RM49.1m (up 21% from FY 2021). Net income: RM16.1m (up 11% from FY 2021). Profit margin: 33% (down from 36% in FY 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 11% per year.
분석 기사 • Aug 30At RM0.86, Is It Time To Put Nova Wellness Group Berhad (KLSE:NOVA) On Your Watch List?While Nova Wellness Group Berhad ( KLSE:NOVA ) might not be the most widely known stock at the moment, it saw...
Reported Earnings • Aug 26Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: RM0.05 (up from RM0.046 in FY 2021). Revenue: RM49.1m (up 21% from FY 2021). Net income: RM15.9m (up 9.4% from FY 2021). Profit margin: 32% (down from 36% in FY 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 100%. Earnings per share (EPS) also missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 18%, compared to a 11% growth forecast for the Personal Products industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 23% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Aug 26Nova Wellness Group Berhad Proposes Single Tier Tax Exempted Final Dividend in Respect of the Financial Year Ended 30 June 2022Nova Wellness Group Berhad announced the recommendation for the declaration and payment of a single tier tax exempted final dividend of 1.25 sen per ordinary share in respect of the financial year ended 30 June 2022, which is subject to the approval of the shareholders of the Company at its forthcoming Annual General Meeting.
분석 기사 • Jul 22Should You Be Adding Nova Wellness Group Berhad (KLSE:NOVA) To Your Watchlist Today?The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Reported Earnings • May 25Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindThird quarter 2022 results: EPS: RM0.015 (up from RM0.011 in 3Q 2021). Revenue: RM12.0m (up 18% from 3Q 2021). Net income: RM4.88m (up 41% from 3Q 2021). Profit margin: 41% (up from 34% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 8.8%. Earnings per share (EPS) missed analyst estimates by 2.6%. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Non Independent & Non Executive Director Seng Loong Sim was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Mar 01Upcoming dividend of RM0.02 per shareEligible shareholders must have bought the stock before 08 March 2022. Payment date: 16 March 2022. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 2.0%. Lower than top quartile of Malaysian dividend payers (4.5%). Higher than average of industry peers (1.6%).
Reported Earnings • Feb 24Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2022 results: EPS: RM0.014 (up from RM0.013 in 2Q 2021). Revenue: RM12.1m (up 21% from 2Q 2021). Net income: RM4.41m (up 8.8% from 2Q 2021). Profit margin: 37% (down from 41% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 8.8%. Earnings per share (EPS) missed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 1.8%, compared to a 11% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 25% per year.
공시 • Feb 24+ 1 more updateNova Wellness Group Berhad Announces Single Tier Tax Exempted Special Dividend for the Financial Year Ending 30 June 2022The Board of Directors of Nova Wellness Group Berhad announced the declaration of a single tier tax exempted interim dividend of 0.8 sen per ordinary share and a single tier tax exempted special dividend of 1.2 sen per ordinary share in respect of the financial year ending 30 June 2022.
Upcoming Dividend • Nov 23Upcoming dividend of RM0.012 per shareEligible shareholders must have bought the stock before 30 November 2021. Payment date: 08 December 2021. Trailing yield: 1.8%. Lower than top quartile of Malaysian dividend payers (4.2%). Higher than average of industry peers (1.5%).
Reported Earnings • Oct 21Full year 2021 earnings released: EPS RM0.046 (vs RM0.041 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: RM40.5m (up 18% from FY 2020). Net income: RM14.6m (up 12% from FY 2020). Profit margin: 36% (down from 38% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.
분석 기사 • Oct 17Nova Wellness Group Berhad's (KLSE:NOVA) Shareholders Will Receive A Bigger Dividend Than Last YearThe board of Nova Wellness Group Berhad ( KLSE:NOVA ) has announced that it will be increasing its dividend on the 8th...
Board Change • Oct 12Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Non Independent & Non Executive Director Seng Loong Sim was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Jul 15Nova Laboratories Sdn. Bhd Announces Temporary Closure of Its OperationThe Board of Directors of Nova Wellness Group Berhad announce that Nova Laboratories Sdn. Bhd., a subsidiary of the Company, is implementing a temporary closure of its operation for 7 days from 12 July 2021 to 18 July 2021 according to the guidance from the Ministry of Health (MOH). The Company had discovered several positive cases of COVID-19 infection among its factory workers. The employees who have tested positive are currently placed under quarantine and isolation. The temporary closure is not expected to have a significant impact on the financial performance of Nova Group. However, it is expected to result in the minor deferment of shipment to its customers throughout the temporary closure period. The Group will take the following actions: Conduct sanitisation work in its factory; Conduct COVID-19 test for workers that had been in close contact with those that were tested COVID-19 positive via contact tracing; and Implement quarantine measures for the affected workers and close contacts in adherence to advice from the MOH.
Executive Departure • May 27Independent & Non-Executive Chairman Abdul bin Mohamad Radzi has left the companyOn the 18th of May, Abdul bin Mohamad Radzi's tenure as Independent & Non-Executive Chairman ended after 3.5 years in the role. As of March 2021, Abdul personally held 520.00k shares (RM234k worth at the time). A total of 2 executives have left over the last 12 months.
Reported Earnings • May 20Third quarter 2021 earnings released: EPS RM0.011 (vs RM0.009 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: RM10.2m (up 16% from 3Q 2020). Net income: RM3.46m (up 27% from 3Q 2020). Profit margin: 34% (up from 31% in 3Q 2020). The increase in margin was driven by higher revenue.
분석 기사 • Mar 28Are Dividend Investors Making A Mistake With Nova Wellness Group Berhad (KLSE:NOVA)?Could Nova Wellness Group Berhad ( KLSE:NOVA ) be an attractive dividend share to own for the long haul? Investors are...
분석 기사 • Mar 10With EPS Growth And More, Nova Wellness Group Berhad (KLSE:NOVA) Is InterestingIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Is New 90 Day High Low • Mar 05New 90-day low: RM0.85The company is down 10.0% from its price of RM0.94 on 04 December 2020. The Malaysian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 1.0% over the same period.
분석 기사 • Feb 20Dividend Investors: Don't Be Too Quick To Buy Nova Wellness Group Berhad (KLSE:NOVA) For Its Upcoming DividendNova Wellness Group Berhad ( KLSE:NOVA ) is about to trade ex-dividend in the next three days. You will need to...
Reported Earnings • Feb 12Second quarter 2021 earnings released: EPS RM0.013 (vs RM0.011 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: RM10.0m (up 13% from 2Q 2020). Net income: RM4.06m (up 14% from 2Q 2020). Profit margin: 41% (in line with 2Q 2020).
분석 기사 • Feb 05Declining Stock and Decent Financials: Is The Market Wrong About Nova Wellness Group Berhad (KLSE:NOVA)?It is hard to get excited after looking at Nova Wellness Group Berhad's (KLSE:NOVA) recent performance, when its stock...
분석 기사 • Jan 19Did Nova Wellness Group Berhad's (KLSE:NOVA) Share Price Deserve to Gain 79%?If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...
공시 • Jan 08+ 1 more updateNova Wellness Group Berhad Announces Demise of Munavvar Zubaid Bin Abdul Sattar, Member of Remuneration CommitteeNova Wellness Group Berhad announced Demise of MUNAVVAR ZUBAID BIN ABDUL SATTAR, Member of Remuneration Committee. Date of change is 06 January 2021.
분석 기사 • Jan 01Has Nova Wellness Group Berhad (KLSE:NOVA) Got What It Takes To Become A Multi-Bagger?Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Is New 90 Day High Low • Dec 31New 90-day low: RM0.86The company is down 5.0% from its price of RM0.92 on 02 October 2020. The Malaysian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 8.0% over the same period.
분석 기사 • Dec 14Key Things To Watch Out For If You Are After Nova Wellness Group Berhad's (KLSE:NOVA) 1.6% DividendCould Nova Wellness Group Berhad ( KLSE:NOVA ) be an attractive dividend share to own for the long haul? Investors are...
분석 기사 • Nov 26Nova Wellness Group Berhad (KLSE:NOVA) Stock Goes Ex-Dividend In Just Four DaysSome investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
분석 기사 • Nov 20With EPS Growth And More, Nova Wellness Group Berhad (KLSE:NOVA) Is InterestingLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Reported Earnings • Nov 17First quarter 2021 earnings released: EPS RM0.009The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: RM9.05m (up 51% from 1Q 2020). Net income: RM2.69m (up 45% from 1Q 2020). Profit margin: 30% (down from 31% in 1Q 2020). The decrease in margin was driven by higher expenses.
Reported Earnings • Oct 21Full year earnings released - EPS RM0.041Over the last 12 months the company has reported total profits of RM13.0m, up 19% from the prior year. Total revenue was RM34.3m over the last 12 months, up 15% from the prior year. Profit margins were 38%, which is higher than the 37% margin from last year. The increase in margin was driven by higher revenue.